"The science shows that there is greater benefit from pulmonary rehab than any pharmacology we can give a COPD patient, so a ...

Walking is a fundamental activity for maintaining health. While numerous studies have assessed how much people with chronic ...

Yet thanks to a new hospital-based educational and advocacy initiative for COPD patients, Croswell has been managing well at ...

People with COPD are vulnerable to small increases in PM2.5, with each 1 μg/m3 rise in long-term exposure linked to a 3.8% ...

Topline results were announced from two phase 3 trials evaluating itepekimab in former smokers with inadequately controlled COPD.

Sanofi and Regeneron have reported that the Phase III AERIFY-1 trial of the fully human monoclonal antibody itepekimab.

Chronic obstructive pulmonary disease (COPD) affects millions of Americans, with new data from the National Center for Health Statistics showing the condition becomes increasingly common as people age ...

(Reuters) -Regeneron shares fell nearly 18% on Friday after its experimental drug for patients with a type of lung condition ...

Long-term health care utilization is greater among patients with COPD who have tested positive for COVID-19 and are unvaccinated.

Sanofi’s plans to submit itepekimab to regulators for approval this year have been thrown into doubt after the ...

People who lost weight in midlife were less likely to experience heart attacks, strokes, cancer, asthma or chronic ...